Schedule 13G ownership disclosure

Evolent Health Inc

Common Stock · CUSIP: 30050B101

Event date: 2025-12-31

Filing-level shares
8,914,065
Percent of class
7.98%
  • The Vanguard Group

    Shares: 8,914,065 · Class: 7.98%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-26-000153
Form type
SCHEDULE 13G/A
Filer
Evolent Health, Inc.
CIK
CIK 1628908
Filed
Jan 30, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub